Alaunos Therapeutics, Inc. SEC filings TCRT
Alaunos Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Apr 1, 2010. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 21, 2026 | — |
| S-8 | Employee stock plan registration | Jul 6, 2026 | — |
| 424B8 | Filing | Dec 11, 2025 | — |
| S-3/A | Filing | Nov 7, 2025 | — |
| S-1 | Registration statement | Oct 22, 2025 | — |
| S-3/A | Filing | Oct 2, 2025 | — |
| S-3/A | Filing | Sep 9, 2025 | — |
| S-3 | Shelf registration | Aug 21, 2025 | — |
| 424B3 | Prospectus | Jun 24, 2025 | — |
| 424B5 | Prospectus supplement | Nov 30, 2022 | — |
| 424B5 | Prospectus supplement | Nov 28, 2022 | — |
| 424B5 | Prospectus supplement | Sep 7, 2022 | — |
| S-3/A | Filing | Aug 31, 2022 | — |
| S-3 | Shelf registration | Aug 12, 2022 | — |
| S-8 | Employee stock plan registration | Mar 30, 2022 | — |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| S-8 | Employee stock plan registration | May 8, 2020 | — |
| 424B5 | Prospectus supplement | Feb 5, 2020 | — |
| 424B5 | Prospectus supplement | Feb 4, 2020 | — |
| 424B7 | Filing | Oct 23, 2019 | — |
| S-3ASR | Automatic shelf registration | Jun 21, 2019 | — |
| 424B3 | Prospectus | Feb 22, 2019 | — |
| S-3 | Shelf registration | Feb 7, 2019 | — |
| S-8 | Employee stock plan registration | Nov 9, 2018 | — |
| S-8 | Employee stock plan registration | Oct 4, 2017 | — |
| 424B5 | Prospectus supplement | May 12, 2017 | — |
| 424B7 | Filing | Apr 1, 2015 | — |
| 424B5 | Prospectus supplement | Feb 4, 2015 | — |
| 424B5 | Prospectus supplement | Feb 2, 2015 | — |
| S-3ASR | Automatic shelf registration | Feb 2, 2015 | — |
| 424B3 | Prospectus | Nov 26, 2014 | — |
| S-8 | Employee stock plan registration | Oct 14, 2014 | — |
| 424B5 | Prospectus supplement | Oct 24, 2013 | — |
| 424B5 | Prospectus supplement | Oct 22, 2013 | — |
| S-8 | Employee stock plan registration | Dec 12, 2012 | — |
| 424B3 | Prospectus | Feb 3, 2012 | — |
| 424B5 | Prospectus supplement | Jan 23, 2012 | — |
| FWP | Free writing prospectus | Jan 20, 2012 | — |
| 424B5 | Prospectus supplement | Jan 19, 2012 | — |
| S-3 | Shelf registration | Nov 7, 2011 | — |
| S-3/A | Filing | Jul 1, 2011 | — |
| S-3 | Shelf registration | May 18, 2011 | — |
| 424B3 | Prospectus | Apr 27, 2011 | — |
| 424B3 | Prospectus | Mar 4, 2011 | — |
| 424B5 | Prospectus supplement | Feb 7, 2011 | — |
| 424B5 | Prospectus supplement | Feb 2, 2011 | — |
| S-8 | Employee stock plan registration | Jul 1, 2010 | — |
| 424B5 | Prospectus supplement | May 27, 2010 | — |
| FWP | Free writing prospectus | May 27, 2010 | — |
| 424B5 | Prospectus supplement | May 26, 2010 | — |
| S-3/A | Filing | May 10, 2010 | — |
| S-3 | Shelf registration | Apr 30, 2010 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TCRT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1107421
- Former names
- ZIOPHARM ONCOLOGY INC (until Jan 4, 2022); EASYWEB INC (until Sep 19, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.